Skip to main
  1. Stocks
  2. Universal Health Services
  3. Forecast
UHS

UHS Stock Forecast & Price Target

UHS Analyst Ratings

Based on 11 analyst ratings
Buy
Strong Buy 27%
Buy 9%
Hold 64%
Sell 0%
Strong Sell 0%

Bulls say

Universal Health Services is supported by a durable mix of scale and margin, with 346 inpatient behavioral health centers, 29 acute care hospitals, and supportive outpatient facilities generating more than 55% of revenue from acute care while behavioral health contributes over 55% of pretax profits. Its leadership in higher-margin behavioral services, especially across Nevada, Texas, and California, gives it attractive profit concentration, though Medicaid reimbursement headwinds and UK exposure add some earnings variability. Even after a tough 3Q26 and slower de novo ramp, improving volumes, cost controls, and new capacity maturation create a credible path to stronger margin expansion and better execution.

Bears say

Universal Health Services is facing a weakening earnings mix as acute care pricing deteriorates, with same-facility revenue per adjusted admission down 1.7% and SS acute margin falling to 11.3%, while surgeries continue migrating to outpatient settings. Behavioral health remains the higher-margin engine, but SS margin still slipped to 17.9% amid DPP headwinds, Laurel Ridge losses, and slower-than-expected de novo ramps at Cedar Hill and the new FL facility. Even with revenue guidance of $18.5B-$18.8B and FY2026 Adj EBITDA-MI toward the low end of $2,610MM-$2,717MM, the 2027 outlook is burdened by a $175MM-$200MM Medicaid supplemental reduction, at least a $15MM exchange headwind, and possible Medicaid work requirement pressure.

UHS has been analyzed by 11 analysts, with a consensus rating of Buy. 27% of analysts recommend a Strong Buy, 9% recommend Buy, 64% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Universal Health Services and is not a guaranteed prediction by Public.com or investment advice.

UHS Analyst Forecast & Price Prediction

Get the latest UHS stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in UHS

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Universal Health Services (UHS) Forecast

Analysts have given UHS a Buy based on their latest research and market trends.

According to 11 analysts, UHS has a Buy consensus rating as of Nov 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $199, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $199, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Universal Health Services (UHS)


UHS Analyst Forecast & Price Prediction

Get the latest UHS stock forecast, including analyst ratings and price predictions, with real-time AI-powered fundamental data and custom analysis

Start investing in UHS

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.
Uncover UHS stock data and trends